Pacific Biosciences of California PACB Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's other income (expense)?
- Pacific Biosciences of California (PACB) reported other income (expense) of $2.01M in Q1 2026.
- How has Pacific Biosciences of California's other income (expense) changed year-over-year?
- Pacific Biosciences of California's other income (expense) decreased by 53.3% year-over-year, from $4.29M to $2.01M.
- What is the long-term trend for Pacific Biosciences of California's other income (expense)?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's other income (expense) has grown at a 254.9% compound annual growth rate (CAGR), from $93K to $14.76M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.